Artificial liver device tested in 10 patients with acute liver failure
Disease control
Completed
This early-phase study tested a device called miroliverELAP in 10 adults with acute liver failure. The device works outside the body to support the liver for up to 48 hours, giving time for the liver to recover or for a transplant to be found. The main goals were to check safety …
Phase: PHASE1 • Sponsor: Miromatrix Medical Inc. • Aim: Disease control
Last updated May 18, 2026 12:02 UTC